Geovax Story

<div class='circular--portrait' style='background:#82ADFD;color: #ffffff;font-size:4em;'>GL</div>
GOVX -- USA Stock  

USD 4.81  0.05  1.03%

While some baby boomers are getting worried about healthcare space, it is reasonable to break down Geovax Labs against economic and market trends. We are going to address the reasons why we are still confident in anticipation of a recovery. Geovax Labs very regressive towards the market. A lot of the latest Geovax Labs price movement was an exact opposite of how the market moved in the last few months. Strong basic indicators of the company may suggest signs of short-term price drift for investors. Geovax Labs is scheduled to announce its earnings today.
Published over three weeks ago
View all stories for Geovax Labs | View All Stories
Will Geovax Labs (NASDAQ:GOVX) continue to slide in April?
Geovax Labs's average rating is Strong Buy from 1 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Geovax Labs market sentiment investors' perception of the future value of Geovax. Let us look at a few aspects of Geovax technical analysis. About 14.0% of the company shares are held by company insiders. Geovax Labs has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. The entity recorded a loss per share of 5.14. The firm had not issued any dividends in recent years. Geovax Labs had 1-20 split on the 25th of September 2020.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Geovax Labs. In general, we focus on analyzing Geovax Labs stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Geovax Labs's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Geovax Labs's intrinsic value. In addition to deriving basic predictive indicators for Geovax Labs, we also check how macroeconomic factors affect Geovax Labs price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Geovax Labs' stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Geovax Labs in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Geovax Labs. Your research has to be compared to or analyzed against Geovax Labs' peers to derive any actionable benefits. When done correctly, Geovax Labs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Geovax Labs.

How does Geovax Stands against Peers?

Analyzing Geovax Labs competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Geovax Labs across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Geovax Labs Competition Details

How Geovax utilizes its cash?

To perform a cash flow analysis of Geovax Labs, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Geovax Labs is receiving and how much cash it distributes out in a given period. The Geovax Labs cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Geovax Labs Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. Geovax Labs reported Net Cash Flow from Operations of (2.75 Million) in 2020

Purchase by Dean Kollintzas of 11987 shares of GEOVAX LABS

Legal trades by Geovax Labs insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
GEOVAX insider trading alert for perchase of common stock purchase warrant by Dean Kollintzas, the corporate stakeholder, on 29th of September 2020. This event was filed by Geovax Labs Inc with SEC on 2020-09-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Closer look at Geovax Labs Semi Deviation

Geovax Labs has current Semi Deviation of 7.0. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.

Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Deviation 
=  
SQRT(SV) 
 = 
7.0
SQRT = Square root notation
SV =   Geovax Labs semi variance of returns over selected period
Let's now compare Geovax Labs Semi Deviation to its closest peers:
GOVX
EQ
DMAC
DRNA
DTIL
GOVX7.001669812915338
EQ4.61
DMAC4.05
DRNA3.46
DTIL4.65

Another setback for Geovax Labs investors

Treynor Ratio just dropped to -0.99, may suggest upcoming price decrease. Geovax Labs is displaying above-average volatility over the selected time horizon. Investors should scrutinize Geovax Labs independently to ensure intended market timing strategies are aligned with expectations about Geovax Labs volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Geovax Labs' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Geovax Labs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Takeaway on Geovax Labs Investment

While some other entities under the biotechnology industry are still a bit expensive, Geovax Labs may offer a potential longer-term growth to investors. To conclude, as of the 23rd of March 2021, our research shows that Geovax Labs is a rather very risky investment opportunity with a very small odds of financial distress in the next two years. From a slightly different view, the entity currently appears to be undervalued. Our up-to-date 30 days buy-or-sell advice on the company is Cautious Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Geovax Labs. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com